Mar 28, 2020
Landmark Phase 3 VOYAGER PAD Study of XARELTO® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
Mar 09, 2020
The psoriatic arthritis treatment market was valued at $7,860 million in 2018, and is estimated to reach at $13,744 million by 2026, registering a CAGR of 7.2% from 2019 to 2026
Dec 16, 2019
Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain
Jan 30, 2019
Researchers Find Antidepressants Significantly Increase Risk of Gastrointestinal, Intracranial Bleeding
Oct 05, 2018
Gastrointestinal Drugs Market to Grow at 4.90% CAGR by 2024, due to Growing Investment for Development of Novel Drugs, TMR Observes
Sep 07, 2018
Scilex Presents ZTlido(TM) Data on Superior Adhesion over Lidocaine Patch Formulation
Aug 27, 2018
Sunascen Therapeutics LLC Announces a New Line of OTC Pain Relievers Based on the Wong-Baker FACES® Pain Rating Scale
Apr 24, 2018
Veterinary Pain Management Market to Grow at 8.0% CAGR to 2023
Apr 20, 2018
Veterinary Pain Management Market Worth 1.66 Billion USD by 2023
Jan 18, 2018
Elanco Innovations Named Best Products for 2017
Jan 18, 2018
GALLIPRANT® (grapiprant tablets) Named Best Companion Animal Product for 2017
Nov 02, 2017
US Market Report for Ankylosing Spondylitis Immunology Drugs 2018 - Unit Sales, ASPs, Market Value & Growth Trends
Sep 07, 2017
The Launch of First-in-Class Biologic Therapies Will Drive Significant Growth Within the Osteoarthritic Pain Market Through 2026
Aug 27, 2017
XARELTO® (rivaroxaban) Significantly Reduced Major Cardiovascular Events in Patients with Stable Coronary and Peripheral Artery Disease in Pivotal Phase 3 Study
Jul 31, 2017
Xatmep - The First and Only Ready-To-Use Methotrexate Oral Solution is Now Available
Jun 12, 2017
Assisi Animal Health Discusses What to Give Your Cat for Pain